References
1. Eckel HE, Bradley PJ. Natural History of Treated and Untreated
Hypopharyngeal Cancer. Adv Otorhinolaryngol . 2019; 27-34.
doi:10.1159/000492305
2. Chandrasekharappa SC, Chinn SB, Donovan FX, et al. Assessing the
spectrum of germline variation in Fanconi anemia genes among patients
with head and neck carcinoma before age 50. Cancer .
2017;123(20):3943–3954. doi:10.1002/cncr.30802
3. Delahaye-Sourdeix M, Anantharaman D, Timofeeva MN, et al. A Rare
Truncating BRCA2 Variant and Genetic Susceptibility to Upper
Aerodigestive Tract Cancer. J Natl Cancer Inst . 2015;107(5).
doi:10.1093/jnci/djv037
4. Kemp SRM-D, Brink A, Meulen IHVD, et al. The FA/BRCA Pathway
Identified as the Major Predictor of Cisplatin Response in Head and Neck
Cancer by Functional Genomics. Mol Cancer Ther .
2016;16(3):540-550. doi:10.1158/1535-7163.mct-16-0457
5. Wattenberg, M.M., Asch, D., Yu, S. et al. Platinum response
characteristics of patients with pancreatic ductal adenocarcinoma and a
germline BRCA1, BRCA2 or PALB2 mutation. Br J
Cancer 122, 333–339 (2020).
https://doi.org/10.1038/s41416-019-0582-7
Figure 1: T2 weighted axial MRI image of tumor invading right
thyroid cartilage and encasing right carotid.
Figure 2: Right piriform sinus mass extending to right
pharyngeal wall with minimal medial disruption in appearance of glottic
and supraglottic structures.